VEGFA and diabetic macular edema: In this regard, intravitreal corticosteroid alleviates diabetic macular edema by targeting the inflammatory cascade via diminishing the production and release of VEGF and other pro-inflammatory mediators, thereby hindering the formation of diabetic macular edema among diabetic patients who received cataract surgeries.